Krzysztof Brzozowski

Krzysztof Brzozowski

Auto-generated profile, based on publicly available information

Krzysztof Brzozowski

Military Institute of Medicine, Warsaw, Poland

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2015 in Medical Science Monitor
Verified
Journal Article
Open access
PDF file
PZPiotr Zięcina
Piotr Zięcina
TZTomasz Zabkowski
Tomasz Zabkowski
PPPiotr Piasecki
Piotr Piasecki
HZHenryk Zieliński
Henryk Zieliński
AWAndrzej Wieczorek
Andrzej Wieczorek
KBKrzysztof Brzozowski
Krzysztof Brzozowski
The aim of this study was to evaluate the efficacy of superselective renal artery embolization in patients with bleeding into the urinary system. From 2007 to 2012, 20 patients were treated with superselective renal artery embolization for bleeding after percutaneous nephrolithotomy (PCNL), nephron-sparing surgery (NSS), including 1 patient with AVF after PCNL. During the procedure, embolization material was injected through a microcatheter to stop the bleeding. Embolization materials included a mixture of cyanoacrylate and lipiodol, embolization coils, and Spongostan. Clinical evaluation included remission of hematuria and normalization of blood morphotic elements. The cause of bleeding into the urinary tract was damage to vessels (all cases): with coexisting false aneurism (8 cases); with coexisting arterio-venus fistula (1 case); and with coexisting intrarenal hematoma (3 cases). The bleeding occurred 2–5 days after PCNL and NSS, and 10 days after PCNL with AVF. The mean hematocrit level was 22%–24%. Technical success was achieved in 20 cases. Clinical success was achieved in 19 cases. One patient with hematuria after PCNL with AVF needed a second endovascular treatment to stop bleeding. Superselective renal artery embolization is an effective procedure in the treatment of iatrogenic bleeding into the urinary tract after PCNL and NSS.

1 June 2012 in European Journal of Radiology
Verified
Journal Article
Closed access
KBKrzysztof Brzozowski
Krzysztof Brzozowski
PPPiotr Piasecki
Piotr Piasecki
PZPiotr Zięcina
Piotr Zięcina
EFEmilia Frankowska
Emilia Frankowska
AJAndrzej Jaroszuk
Andrzej Jaroszuk
RBRomana Bogusławska-Walecka
Romana Bogusławska-Walecka

31 December 2011 in European Journal of Radiology
Verified
Journal Article
Closed access
KBKrzysztof Brzozowski
Krzysztof Brzozowski
EFEmilia Frankowska
Emilia Frankowska
PPPiotr Piasecki
Piotr Piasecki
PZPiotr Zięcina
Piotr Zięcina
PŻPaweł Żukowski
Paweł Żukowski
RBRomana Bogusławska-Walecka
Romana Bogusławska-Walecka

10 July 2018 in PLOS ONE
Verified
Journal Article
Open access
PDF file
PPPiotr Piasecki
Piotr Piasecki
Jerzy NarlochJerzy Narloch
Jerzy Narloch
KBKrzysztof Brzozowski
Krzysztof Brzozowski
PZPiotr Zięcina
Piotr Zięcina
AMAndrzej Mazurek
Andrzej Mazurek
MDMirosław Dziuk
Mirosław Dziuk
The aim of this study was to evaluate a modified method of calculating the 99mTc/90Y tumor-to-normal-liver uptake ratio (mT/N) based on SPECT/CT imaging, for use in predicting the overall response of colorectal liver tumors after radioembolization. A modified phantom-based method of tumor-to-normal-liver ratio calculation was proposed and assessed. In contrast to the traditional method based on data gathered from the whole tumor, gamma counts are collected only from a 2D region of interest delineated in the SPECT/CT section with the longest tumor diameter (as specified in RECIST 1.1). The modified tumor-to-normal-liver ratio (mT/N1) and 90Y predicted tumor absorbed dose (PAD) were obtained based on 99mTc-MAA SPECT/CT, and similarly the modified tumor-to-normal-liver ratio (mT/N2) and 90Y actual tumor absorbed dose (AAD) were calculated after 90Y-SPECT/CT. Tumor response was assessed on follow-up CTs. Using the newly proposed method, a total of 103 liver colorectal metastases in 21 patients who underwent radioembolization (between June 2009 and October 2015) were evaluated in pre-treatment CT scans and 99mTc-MAA-SPECT/CT scans and compared with post-treatment 90Y-SPECT/CT scans and follow-up CT scans. The results showed that the mT/N1 ratio (p = 0.012), PAD (p < 0.001) and AAD (p < 0.001) were predictors of tumor response after radioembolization. The time to progression was significantly lengthened for tumors with mT/N1 higher than 1.7 or PAD higher than 70 Gy. The risk of progression for tumors with mT/N1 lower than 1.7 or PAD below 70 Gy was significantly higher. The mT/N2 ratio had no significant correlation with treatment results. The mT/N1 ratio, PAD, and AAD can be used as predictors of tumor response to SIRT treatment, and SPECT/CT imaging can be used for dosimetric assessment of radioembolization.

22 October 2013 in Endocrine
Verified
Journal Article
Open access
PDF file
GKGrzegorz Wiktor Kamiński
Grzegorz Wiktor Kamiński
AJAndrzej Jaroszuk
Andrzej Jaroszuk
AZAriadna Zybek-Kocik
Ariadna Zybek-Kocik
KBKrzysztof Brzozowski
Krzysztof Brzozowski
PPPiotr Piasecki
Piotr Piasecki
MRMarek Ruchala
Marek Ruchala
In search of new treatment options for thyroid diseases, when conventional procedures are ineffective, contraindicated or associated with serious side effects, safety of thyroid arteries embolization in the treatment of particular thyroid diseases was evaluated. The study included eight subjects with retrosternal toxic goiter, six patients affected by Graves' disease, five cases of retrosternal non-toxic goiter, two subjects with post-amiodarone hyperthyroidism, and one patient with severe thyroid-related orbitopathy, who underwent selective embolization of thyroid arteries. The study assessed and compared calcium-phosphate balance, modulation of thyroid autoimmunity and the presence of different side effects in patients who underwent the procedure. In addition, the serum concentrations of thyroid hormones, anti-thyroid autoantibodies and thyroid volume have been measured. Five of all enrolled subjects (22.7 %) experienced transient, not clinically relevant hypocalcaemia with no need for calcium supplementation. There were no significant changes in serum calcium levels in patients after embolization of both inferior thyroid arteries. The transient side effects associated with the treatment were neck pain and a slight increase in body temperature. Noted high concentration of free thyroid hormones immediately after the procedure was not accompanied by worsening of symptoms or signs of thyrotoxicosis. In patients with Graves' disease, a significant decrease in thyrotropin receptor antibodies level was observed. Thyroid arterial embolization does not disturb permanently calcium-phosphate balance, modulates positively thyroid autoimmune processes and is associated with no serious post-procedure side effects. Hence, it may be considered as a safe and effective treatment modality for selected thyroid disorders.

1 September 2017 in Neurologia i Neurochirurgia Polska
Verified
Journal Article
Closed access
ASAgnieszka Słowik
Agnieszka Słowik
MWMarcin Wnuk
Marcin Wnuk
PBPaweł Brzegowy
Paweł Brzegowy
JCJoanna Chrzanowska-Waśko
Joanna Chrzanowska-Waśko
AGAleksandra Golenia
Aleksandra Golenia
TPTadeusz J. Popiela
Tadeusz J. Popiela
Mechanical thrombectomy (MT) is not reimbursed by the Polish public health system. We present a description of 5 years of experience with MT in acute stroke in Comprehensive Stroke Centers (CSCs) in Poland. We retrospectively analyzed the results of a structured questionnaire from 23 out of 25 identified CSCs and 22 data sets that include 61 clinical, radiological and outcome measures. Most of the CSCs (74%) were founded at University Hospitals and most (65.2%) work round the clock. In 78.3% of them, the working teams are composed of neurologists and neuro-radiologists. All CSCs perform CT and angio-CT before MT. In total 586 patients were subjected to MT and data from 531 of them were analyzed. Mean time laps from stroke onset to groin puncture was 250±99min. 90.3% of the studied patients had MT within 6h from stroke onset; 59.3% of them were treated with IV rt-PA prior to MT; 15.1% had IA rt-PA during MT and 4.7% - emergent stenting of a large vessel. M1 of MCA was occluded in 47.8% of cases. The Solitaire device was used in 53% of cases. Successful recanalization (TICI2b-TICI3) was achieved in 64.6% of cases and 53.4% of patients did not experience hemorrhagic transformation. Clinical improvement on discharge was noticed in 53.7% of cases, futile recanalization - in 30.7%, mRS of 0-2 - in 31.4% and mRS of 6 in 22% of cases. Our results can help harmonize standards for MT in Poland according to international guidelines.